WallStreetZenWallStreetZen

NASDAQ: CSBR
Champions Oncology Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CSBR past revenue growth

How has CSBR's revenue growth performed historically?
Company
-8.29%
Industry
151.46%
Market
17.61%
CSBR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CSBR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CSBR's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CSBR earnings and revenue history

Current Revenue
$49.2M
Current Earnings
-$9.7M
Current Profit Margin
-19.8%

CSBR Return on Equity

Current Company
-850.7%
Current Industry
-63.5%
Current Market
188%
CSBR's Return on Equity (-850.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CSBR announces earnings.

CSBR Return on Assets

Current Company
-32.6%
Current Industry
2.9%
CSBR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CSBR Return on Capital Employed

Current Company
-200.46%
Current Industry
19.5%
CSBR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CSBR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CSBR$49.22M-$7.67M-$9.73M+15.19%N/A
MNOV$1.00M-$8.35M-$8.57M-50.23%N/A
CRVS$0.00-$26.88M-$27.03MN/AN/A
LABP$0.00-$21.94M-$21.94MN/AN/A
TIL$0.00-$145.48M-$156.09M-100.00%N/A
View Top Biotech Stocks

Champions Oncology Earnings & Revenue FAQ

What were CSBR's earnings last quarter?

On Invalid Date, Champions Oncology (NASDAQ: CSBR) reported Q4 2023 earnings per share (EPS) of -$0.19, up 5.56% year over year. Total Champions Oncology earnings for the quarter were -$2.53 million. In the same quarter last year, Champions Oncology's earnings per share (EPS) was -$0.18.

If you're new to stock investing, here's how to buy Champions Oncology stock.

What was CSBR's earnings growth in the past year?

As of Q2 2024, Champions Oncology's earnings has grown year over year. Champions Oncology's earnings in the past year totalled -$9.73 million.

What was CSBR's revenue last quarter?

On Invalid Date, Champions Oncology (NASDAQ: CSBR) reported Q4 2023 revenue of $12.02 million up 5.9% year over year. In the same quarter last year, Champions Oncology's revenue was $12.77 million.

What was CSBR's revenue growth in the past year?

As of Q2 2024, Champions Oncology's revenue has grown -8.29% year over year. This is 159.75 percentage points lower than the US Biotechnology industry revenue growth rate of 151.46%. Champions Oncology's revenue in the past year totalled $49.22 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.